CN101850017B - Chinese medicament for treating asthma - Google Patents
Chinese medicament for treating asthma Download PDFInfo
- Publication number
- CN101850017B CN101850017B CN2009102354866A CN200910235486A CN101850017B CN 101850017 B CN101850017 B CN 101850017B CN 2009102354866 A CN2009102354866 A CN 2009102354866A CN 200910235486 A CN200910235486 A CN 200910235486A CN 101850017 B CN101850017 B CN 101850017B
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- chinese
- radix
- asthma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 28
- 208000006673 asthma Diseases 0.000 title claims abstract description 21
- 241000222336 Ganoderma Species 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 4
- 239000000843 powder Substances 0.000 claims description 17
- 239000002775 capsule Substances 0.000 claims description 16
- 241000237636 Pheretima Species 0.000 claims description 11
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 10
- 241000180649 Panax notoginseng Species 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- 241001446509 Psoralea Species 0.000 claims description 6
- 241000405414 Rehmannia Species 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 238000003809 water extraction Methods 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 15
- 239000008280 blood Substances 0.000 abstract description 7
- 210000004369 blood Anatomy 0.000 abstract description 7
- 210000003734 kidney Anatomy 0.000 abstract description 6
- 210000004072 lung Anatomy 0.000 abstract description 5
- 230000008901 benefit Effects 0.000 abstract description 4
- 238000005728 strengthening Methods 0.000 abstract description 4
- 230000017531 blood circulation Effects 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 244000131316 Panax pseudoginseng Species 0.000 abstract description 2
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract description 2
- 208000023504 respiratory system disease Diseases 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 244000241463 Cullen corylifolium Species 0.000 abstract 1
- 241000218671 Ephedra Species 0.000 abstract 1
- 241000361919 Metaphire sieboldi Species 0.000 abstract 1
- 240000006079 Schisandra chinensis Species 0.000 abstract 1
- 230000001502 supplementing effect Effects 0.000 abstract 1
- 208000000059 Dyspnea Diseases 0.000 description 6
- 206010013975 Dyspnoeas Diseases 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 3
- 241000207961 Sesamum Species 0.000 description 3
- 235000003434 Sesamum indicum Nutrition 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- AXONCVPTTFHNOI-UHFFFAOYSA-N kairine Chemical compound C1=CC(O)=C2N(C)CCCC2=C1 AXONCVPTTFHNOI-UHFFFAOYSA-N 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229940126678 chinese medicines Drugs 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 229960002819 diprophylline Drugs 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- KSCFJBIXMNOVSH-UHFFFAOYSA-N dyphylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1N(CC(O)CO)C=N2 KSCFJBIXMNOVSH-UHFFFAOYSA-N 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 210000000088 lip Anatomy 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese medicament for treating asthma, and belongs to the field of Chinese medicaments for treating respiratory diseases. The Chinese medicament aims to have good effect and quick response. The Chinese medicament is prepared from raw materials such as ephedra, radix pseudo-ginseng, rehmanniae vaporata, Chinese magnoliavine fruit, earthworm, glossy ganoderma, Chinese angelica, malaytea scurfpea fruit and the like. The Chinese medicament has the effects of strengthening body resistance and archaeus, supplementing qi and nourishing blood, promoting blood circulation by removing blood stasis, tonifying the kidney to benefit the lung and alleviating qi and relieving asthma, and has the advantages of obvious effect, definite curative effect and quick response.
Description
Technical field
The invention belongs to the field of Chinese medicines of treatment respiratory disease.
Background technology
At present, be intended to treat the field of Chinese medicines of asthma, exist the deficiency of several aspects: the one, effect is obvious inadequately, and the 2nd, it is slower to take effect.Large quantities of asthma patients can not effectively treat and control this disease because of medicine, thus asthma is shown effect repeatedly, touching difficulty more, the patient is sound, unable to lie due to dyspnea in fullness in the chest with rough breath, the larynx usually, and is very painful.Family numbers of patients is very dissatisfied to this.
At problem set forth above, the invention provides a kind of Chinese medicine for the treatment of asthma, it is obvious inadequately that it can solve in this type of treatment by Chinese herbs in the past effect, the slower problem that takes effect, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, a kind of Chinese medicine for the treatment of asthma adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Herba Ephedrae 4-30 part Radix Notoginseng 3-20 part Radix Rehmanniae Preparata 4-30 part
Fructus Schisandrae Chinensis 4-30 part Pheretima 4-30 part Ganoderma 2-12 part
Radix Angelicae Sinensis 4-30 part Fructus Psoraleae 4-30 part
The Chinese medicine of this treatment asthma is made by following method:
(1) by above-mentioned weight ratio, Herba Ephedrae, Radix Rehmanniae Preparata, Fructus Schisandrae Chinensis, Pheretima, Radix Angelicae Sinensis, Fructus Psoraleae are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.Ganoderma, Radix Rehmanniae Preparata benefiting QI and nourishing blood, nourishing kidney replenishing essence in the side, the body resistance strengthening and constitution consolidating is to be principal agent; Be aided with the Fructus Psoraleae improving inspiration by invigorating the kidney; The Fructus Schisandrae Chinensis the kidney invigorating is astringed the lung, and to strengthen the merit that principal agent is tonified Qi of the kidney, is accessory drugs; Assistant is with Radix Angelicae Sinensis, pseudo-ginseng blood-circulation-invigovating blood stasis dispelling; The descending diuretic of Pheretima, the capable then mechanism of qi of water and smooth; The capable water of Herba Ephedrae lung qi dispersing, the capable then diprophylline of lung Xuan Shui.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, and blood circulation promoting and blood stasis dispelling, the kidney invigorating lung benefiting, the merit of lowering the adverse-rising QI to relieve dyspnea, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
Herba Ephedrae 60 gram Radix Notoginseng 40 gram Radix Rehmanniaes Preparata 60 grams
Fructus Schisandrae Chinensis 60 gram Pheretimas 60 kairine sesames 30 grams
Radix Angelicae Sinensis 60 gram Fructus Psoraleaes 60 grams
Weight in accordance with regulations, with conventional water extraction process Herba Ephedrae, Radix Rehmanniae Preparata, Fructus Schisandrae Chinensis, Pheretima, Radix Angelicae Sinensis, Fructus Psoraleae are extracted, make extractum fine powder 108 grams, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder, make fine particle, the capsule of packing into No. 0 is made 742 of Chinese medicinal capsules, and every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
Herba Ephedrae 160 gram Radix Notoginseng 120 gram Radix Rehmanniaes Preparata 160 grams
Fructus Schisandrae Chinensis 160 gram Pheretimas 160 kairine sesames 100 grams
Radix Angelicae Sinensis 160 gram Fructus Psoraleaes 160 grams
By above-mentioned same method, make 1671 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
Herba Ephedrae 300 gram Radix Notoginseng 200 gram Radix Rehmanniaes Preparata 300 grams
Fructus Schisandrae Chinensis 300 gram Pheretimas 300 kairine sesames 120 grams
Radix Angelicae Sinensis 300 gram Fructus Psoraleaes 300 grams
By above-mentioned same method, make 3071 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
6 parts in 5 parts of Radix Rehmanniaes Preparata of 6 portions of Radix Notoginseng of Herba Ephedrae
3 parts of 6 portions of Ganodermas of 6 parts of Pheretimas of Fructus Schisandrae Chinensis
6 parts of 6 parts of Fructus Psoraleaes of Radix Angelicae Sinensis
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
25 parts in 16 parts of Radix Rehmanniaes Preparata of 20 portions of Radix Notoginseng of Herba Ephedrae
9 parts of 20 portions of Ganodermas of 20 parts of Pheretimas of Fructus Schisandrae Chinensis
20 parts of 25 parts of Fructus Psoraleaes of Radix Angelicae Sinensis
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science asthma, through 7 routine clinical observations.Selecting tcm diagnosis asthma is standard: patient's limb is soft weak, and is weak on one's body; Usually uncomfortable in chest, pant, cough, dyspnea; Asthma is seasonal outbreak, perhaps cold asthma, perhaps asthma of heat type; Fullness in the chest with rough breath during asthma, the sound pitch breath gushes unable to lie due to dyspnea.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 3 examples, women's 4 examples do not have other serious disease, and the age is 57 years old-79 years old, 70.4 years old mean age.
Efficacy determination:
1, produce effects: body constitution strengthens, on one's body energetically; Uncomfortable in chest, cough, dyspnea are obviously alleviated; The asthma attack number of times reduces, and the time is shorter; Took in 2 months in advance, cold asthma or asthma of heat type outbreak probability reduce.
2, effective: body constitution strengthens, on one's body energetically; Uncomfortable in chest, pant, cough, dyspnea alleviate to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 3 months, is a course of treatment.Instructions of taking: every day 3 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 1 month, take 3 months after, symptom is obviously improved.7 philtrums of clinical experiment, produce effects 3 people, effective 3 people, invalid 1 people, total effective rate 85.7%.
Claims (1)
1. a Chinese medicine for the treatment of asthma is characterized in that, described Chinese medicine is to adopt the raw material of Chinese medicine preparation, and the weight proportion of raw material of Chinese medicine is:
Herba Ephedrae 4---30 parts of 30 portions of Radix Notoginseng 3---20 parts of Radix Rehmanniaes Preparata 4---
Fructus Schisandrae Chinensis 4---12 parts of 30 parts of Pheretimas 4---30 portions of Ganodermas 2---
30 parts of Radix Angelicae Sinensis 4---30 parts of Fructus Psoraleaes 4---
The Chinese medicine of this treatment asthma is made by following method:
(1) by above-mentioned weight ratio, Herba Ephedrae, Radix Rehmanniae Preparata, Fructus Schisandrae Chinensis, Pheretima, Radix Angelicae Sinensis, Fructus Psoraleae are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; Make Chinese medicine granules, powder, capsule, watered pill, tablet.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102354866A CN101850017B (en) | 2009-10-16 | 2009-10-16 | Chinese medicament for treating asthma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102354866A CN101850017B (en) | 2009-10-16 | 2009-10-16 | Chinese medicament for treating asthma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101850017A CN101850017A (en) | 2010-10-06 |
| CN101850017B true CN101850017B (en) | 2011-09-28 |
Family
ID=42801807
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009102354866A Expired - Fee Related CN101850017B (en) | 2009-10-16 | 2009-10-16 | Chinese medicament for treating asthma |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101850017B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104688869A (en) * | 2015-03-19 | 2015-06-10 | 高彬 | TCM (Traditional Chinese Medicine) preparation for treating asthma and preparation method thereof |
-
2009
- 2009-10-16 CN CN2009102354866A patent/CN101850017B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN101850017A (en) | 2010-10-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101530461A (en) | Traditional Chinese medicine for treating nasopharyngeal cancer | |
| CN101850017B (en) | Chinese medicament for treating asthma | |
| CN101843829B (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101884704B (en) | Traditional Chinese medicine for treating asthma | |
| CN101897847B (en) | Traditional Chinese medicine for curing asthma | |
| CN101843698B (en) | Chinese medicament for treating cervical spondylosis | |
| CN101843705B (en) | Chinese medicament for treating lupus erythematosus | |
| CN101884762B (en) | Traditional Chinese medicine for treating emphysema | |
| CN101850078B (en) | Chinese medicament for treating chronic nephritis | |
| CN101843679B (en) | Chinese medicament for treating cervical spondylosis | |
| CN101850018A (en) | Chinese medicament for treating cervical spondylosis | |
| CN101843726B (en) | Chinese medicament for treating chronic hepatitis | |
| CN101850055B (en) | Chinese medicament for treating coronary heart diseases | |
| CN101843717B (en) | Chinese medicament for treating coronary disease | |
| CN101843718B (en) | Chinese medicament for treating lupus erythematosus | |
| CN101850079B (en) | Chinese medicament for treating asthma | |
| CN101850083B (en) | Chinese medicament for treating asthma | |
| CN101850014B (en) | Chinese medicament for treating asthma | |
| CN101843830B (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101879259B (en) | Traditional Chinese medicine for treating pulmonary heart diseases | |
| CN101843844B (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101564476B (en) | Chinese medicament for treating coronary heart disease | |
| CN101843797A (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101843750B (en) | Chinese medicament for treating chronic nephritis | |
| CN101850034B (en) | Chinese medicament for treating angina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: WEI DEZONG Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD. Effective date: 20141218 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100040 SHIJINGSHAN, BEIJING TO: 541105 GUILIN, GUANGXI ZHUANG AUTONOMOUS REGION |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20141218 Address after: 541105, room 2, unit 8, 1 Xing Xing Road, 202 Town, Lingui County, the Guangxi Zhuang Autonomous Region, Lingui Patentee after: Wei Dezong Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 building 10-602 room Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd. |
|
| DD01 | Delivery of document by public notice |
Addressee: Wei De Zong Document name: Notification of Termination of Patent Right |
|
| DD01 | Delivery of document by public notice | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110928 Termination date: 20181016 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |